Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BHCHX vs LHCOX overlap: 52% of top holdings shared

Bottom line

How much do BHCHX and LHCOX overlap?

52% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 46.1% of BHCHX's assets and 43.8% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

BHCHXLHCOX
Weight overlap (top 25)52%
Shared holdings13
Weight in shared holdings46.1%43.8%
Total positions4361
Expense ratio0.85%0.68%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings BHCHX and LHCOX have in common

Holding% of BHCHX% of LHCOXOverlap
Eli Lilly & Co13.66%10.40%10.40%
Johnson & Johnson5.56%4.96%4.96%
Thermo Fisher Scientific Inc3.91%2.31%2.31%
UnitedHealth Group Inc3.28%5.39%3.28%
Edwards Lifesciences Corp2.64%1.78%1.78%
Vertex Pharmaceuticals Inc2.61%2.24%2.24%
AstraZeneca PLC2.49%1.97%1.97%
Guardant Health Inc2.17%2.61%2.17%
Madrigal Pharmaceuticals Inc2.12%1.91%1.91%
Revolution Medicines Inc2.05%1.67%1.67%
Gilead Sciences Inc1.99%3.53%1.99%
Natera Inc1.93%3.60%1.93%
Protagonist Therapeutics Inc1.72%1.44%1.44%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BHCHX

  1. Mettler-Toledo International Inc — 5.60%
  2. Argenx SE — 4.23%
  3. Roivant Sciences Ltd — 3.88%
  4. Teva Pharmaceutical Industries Ltd — 3.86%
  5. Welltower Inc — 3.38%
  6. RadNet Inc — 3.24%
  7. Billiontoone Inc — 2.84%
  8. Merck & Co Inc — 2.48%
  9. Elanco Animal Health Inc — 2.05%
  10. Kymera Therapeutics Inc — 2.01%
  11. Intuitive Surgical Inc — 1.74%
  12. Elevance Health Inc — 1.69%

Only in LHCOX

  1. Novartis AG — 4.19%
  2. CVS Health Corp — 3.33%
  3. Galderma Group AG — 2.60%
  4. Cogent Biosciences Inc — 2.27%
  5. 10X Genomics Inc — 2.16%
  6. BeOne Medicines Ltd — 2.06%
  7. Ascendis Pharma A/S — 1.99%
  8. Bridgebio Pharma Inc — 1.84%
  9. Arrowhead Pharmaceuticals Inc — 1.52%
  10. Dianthus Therapeutics Inc — 1.44%
  11. Adaptive Biotechnologies Corp — 1.42%
  12. Illumina Inc — 1.42%

Asset mix

Asset typeBHCHXLHCOX
Stocks97.7%98.2%
Repurchase agreements—1.2%
Cash & short-term funds—0.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryBHCHXLHCOX
US79.7%78.5%
CH—8.8%
NL4.5%2.2%
BM3.9%1.1%
IL3.9%1.2%
GB2.5%2.0%
DK0.4%2.0%
CA1.9%0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do BHCHX and LHCOX overlap?
About 52% by weight. 13 securities appear in both funds' top 25 holdings; they make up 46.1% of BHCHX's assets and 43.8% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BHCHX and LHCOX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Vertex Pharmaceuticals Inc.
Should I own both BHCHX and LHCOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BHCHX or LHCOX?
LHCOX is broader, with 61 positions versus 43 for BHCHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.